Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large drop in short interest in the month ...

The "UK Blood Typing, Grouping and Infectious Disease NAT Screening Market Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays" report has ...

耶鲁大学医学院Akiko Iwasaki团队在Science Immunology上发表题为"A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses的研究论文。

C3 AI shares jumped Tuesday as the company expanded its partnership with Microsoft to speed adoption of its enterprise AI software. The company's software will be available on the Microsoft ...

C3.AI and Microsoft announce a strategic alliance to accelerate the adoption of Enterprise AI on Microsoft Azure. The agreement establishes C3.AI as a preferred AI application software provider on ...

Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens ...

C3.ai, Inc. (AI) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Numerous monoclonal antibodies that target proinflammatory cytokines or their receptors (e.g. infliximab, adalimumab, tocilizumab, belimumab, HuMax-IL-15), and cell-surface or co-stimulatory ...